Receptor occupancy of dual glucagon-like peptide 1/glucagon receptor agonist sar425899 in individuals with type 2 diabetes

HIGHLIGHTS

• who: Olof Eriksson from the for Life LaboratoryUppsala University have published the research: Receptor occupancy of dual glucagon-like peptide 1/glucagon receptor agonist SAR425899 in individuals with type 2 diabetes, in the Journal: Scientific Reports Scientific Reports
• what: The main reason for this was a high drop out rate of 6 out of 13 subjects enrolled because of AEs.
• future: Studies are required to fully elucidate the potential of the glucagon tracer as a valuable tool for receptor target engagement and drug development.

SUMMARY

This was a phase . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.